GR3004794T3 - - Google Patents

Info

Publication number
GR3004794T3
GR3004794T3 GR920401036T GR920401036T GR3004794T3 GR 3004794 T3 GR3004794 T3 GR 3004794T3 GR 920401036 T GR920401036 T GR 920401036T GR 920401036 T GR920401036 T GR 920401036T GR 3004794 T3 GR3004794 T3 GR 3004794T3
Authority
GR
Greece
Prior art keywords
eye
intraocular pressure
prostaglandin
glaucoma
subject
Prior art date
Application number
GR920401036T
Other languages
Greek (el)
English (en)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21876714&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=GR3004794(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed filed Critical
Publication of GR3004794T3 publication Critical patent/GR3004794T3/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
GR920401036T 1987-04-03 1992-06-04 GR3004794T3 (cg-RX-API-DMAC7.html)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US3448487A 1987-04-03 1987-04-03

Publications (1)

Publication Number Publication Date
GR3004794T3 true GR3004794T3 (cg-RX-API-DMAC7.html) 1993-04-28

Family

ID=21876714

Family Applications (2)

Application Number Title Priority Date Filing Date
GR920401036T GR3004794T3 (cg-RX-API-DMAC7.html) 1987-04-03 1992-06-04
GR20000401411T GR3033721T3 (en) 1987-04-03 2000-06-16 Use of a prostaglandin in combination with an adrenergic blocking agent for reduction of intraocular pressure.

Family Applications After (1)

Application Number Title Priority Date Filing Date
GR20000401411T GR3033721T3 (en) 1987-04-03 2000-06-16 Use of a prostaglandin in combination with an adrenergic blocking agent for reduction of intraocular pressure.

Country Status (9)

Country Link
EP (1) EP0286903B2 (cg-RX-API-DMAC7.html)
JP (1) JP2726672B2 (cg-RX-API-DMAC7.html)
AT (1) ATE76750T1 (cg-RX-API-DMAC7.html)
AU (1) AU607981B2 (cg-RX-API-DMAC7.html)
CA (1) CA1314220C (cg-RX-API-DMAC7.html)
DE (1) DE3871596T3 (cg-RX-API-DMAC7.html)
ES (1) ES2042625T5 (cg-RX-API-DMAC7.html)
GR (2) GR3004794T3 (cg-RX-API-DMAC7.html)
HU (1) HU211835A9 (cg-RX-API-DMAC7.html)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1334168C (en) * 1988-04-26 1995-01-31 Louis M. De Santis Antiglaucoma compositions containing combinations of .alpha.-2 agonists and .beta. blockers
US5173507A (en) * 1988-07-18 1992-12-22 Alcon Laboratories, Inc. Prostaglandin combinations in glaucoma therapy
CA2021316C (en) * 1989-07-27 2000-10-24 Ming Fai Chan Intraocular pressure reducing 11-acyl prostaglandins
US5028624A (en) * 1989-07-27 1991-07-02 Allergan, Inc. Intraocular pressure reducing 9,15-diacyl prostaglandins
US4994274A (en) * 1989-07-27 1991-02-19 Allergan, Inc. Intraocular pressure reducing 11,15-diacyl prostaglandins and method of using
US5055467A (en) * 1989-11-13 1991-10-08 Allergan, Inc. Pharmaceutical epinephrine-pilocarpine compounds
US5198545A (en) * 1989-11-13 1993-03-30 Allergan, Inc. Pharmaceutical epinephrine-pilocarpine compounds and process of preparation thereof
US5011856A (en) * 1990-03-12 1991-04-30 Allergan, Inc. Use of prostaglandin F3 α as an ocular hypotensive agent
ES2059058T3 (es) * 1990-05-22 1994-11-01 R Tech Ueno Ltd Combinacion sinergica para uso oftalmico.
EP0458590B1 (en) * 1990-05-22 1996-01-10 R-Tech Ueno Ltd. Treatment of ocular hypertention with a synergistic combination
ES2069823T3 (es) * 1990-05-22 1995-05-16 R Tech Ueno Ltd Tratamiento de la hipertension ocular con una combinacion sinergica ocular.
US5238961A (en) * 1990-06-14 1993-08-24 Allergan, Inc. Pgf 1-alcohols and their use as ocular hypotensives
TW210287B (cg-RX-API-DMAC7.html) * 1991-03-01 1993-08-01 Kabushikaisha Ueno Seiyaku Oyo Kenkyujo
PT561073E (pt) * 1992-03-19 2002-04-29 R Tech Ueno Ltd Tratamento da hipertensao ocular com beta-bloqueadores e derivados de acido prostanoico
JPH06107547A (ja) * 1992-10-01 1994-04-19 Aarutetsuku Ueno:Kk 眼科用組成物
ES2105333T3 (es) * 1992-10-13 1997-10-16 Alcon Lab Inc Combinaciones de prostaglandinas y derivados de clonidina para el tratamiento del glaucoma.
US5574066A (en) * 1992-10-28 1996-11-12 Allergan Intraocular pressure reducing 15-acyl prostaglandins
SE9402816D0 (sv) * 1994-08-24 1994-08-24 Pharmacia Ab Method and meams for drug administration
US5698733A (en) * 1994-09-30 1997-12-16 Alcon Laboratories, Inc. Use of 9-deoxy prostaglandin derivatives to treat glaucoma
AU746893B2 (en) * 1998-01-23 2002-05-02 Merck Sharp & Dohme B.V. Method for increasing oxygen tension in the optic nerve and retina
CN1259051C (zh) * 2001-04-19 2006-06-14 帝化制药株式会社 药物及药物试剂盒
TWI298257B (en) 2001-05-31 2008-07-01 Allergan Inc Hypotensive lipid and timolol compositions and methods of using same
AU2007200821A1 (en) * 2001-05-31 2007-03-15 Allergan, Inc. Hypotensive lipid and timolol compositions and methods of using same
TW200305424A (en) 2002-01-29 2003-11-01 Santen Pharmaceutical Co Ltd Glaucoma-treating agent comprising bunazosin and prostaglandin
EP1541151B1 (en) * 2002-08-29 2012-02-22 Santen Pharmaceutical Co., Ltd. REMEDY FOR GLAUCOMA COMPRISING Rho KINASE INHIBITOR AND PROSTAGLANDINS
KR101223886B1 (ko) * 2002-11-18 2013-01-17 산텐 세이야꾸 가부시키가이샤 Ｒｈｏ 키나아제 억제제와 β 차단약으로 이루어진 녹내장 치료제
US7186744B2 (en) * 2003-11-13 2007-03-06 Allergan, Inc. Prostamides for the treatment of glaucoma and related diseases
ES2416334T3 (es) 2005-07-12 2013-07-31 Kowa Company. Ltd. Agente para la prevención o el tratamiento del glaucoma
EP2127638A1 (en) * 2008-05-30 2009-12-02 Santen Pharmaceutical Co., Ltd Method and composition for treating ocular hypertension and glaucoma
WO2011034192A1 (ja) * 2009-09-17 2011-03-24 千寿製薬株式会社 ラタノプロストを含有する水性点眼剤、並びにラタノプロストの樹脂への吸着の抑制方法
EP2598118B1 (en) 2010-07-29 2018-09-05 Allergan, Inc. Preservative free bimatoprost and timolol solutions
US9061034B2 (en) 2010-07-29 2015-06-23 Allergan, Inc. Preservative free bimatoprost and timolol solutions
EP2671586B1 (en) 2011-02-04 2018-05-30 Kowa Co., Ltd. Drug therapy for preventing or treating glaucoma
CA3099517C (en) * 2012-07-13 2022-04-26 Santen Pharmaceutical Co., Ltd. Combinations comprising a sulfonamide compound for the treatment of glaucoma or ocular hypertension
WO2018033854A1 (en) 2016-08-15 2018-02-22 Santen Pharmaceutical Co., Ltd. Ophthalmic composition and a method for treating ocular hypertension and glaucoma
KR20200103041A (ko) 2017-12-21 2020-09-01 산텐 세이야꾸 가부시키가이샤 오미데네팍의 조합
ES2972934T3 (es) 2017-12-21 2024-06-17 Santen Pharmaceutical Co Ltd Combinación de sepetaprost y ripasudil para su uso en la profilaxis o tratamiento del glaucoma o hipertensión ocular

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4454154A (en) * 1981-06-23 1984-06-12 American Hospital Supply Corporation Method for treating glaucoma by the topical administration of selectively metabolized beta-blocking agents
US4599353A (en) * 1982-05-03 1986-07-08 The Trustees Of Columbia University In The City Of New York Use of eicosanoids and their derivatives for treatment of ocular hypertension and glaucoma
DE3300933A1 (de) * 1983-01-13 1984-07-19 Boehringer Mannheim Gmbh, 6800 Mannheim Verwendung von d,l- und d-carazolol als antiglaukommittel sowie arzneimittel, die diese stoffe enthalten
DE3785602T2 (de) * 1986-03-13 1993-09-02 Univ Columbia Verwendung von a-, b- und c-prostaglandinen und deren derivaten zur behandlung von augen-hypertension und glaukom.

Also Published As

Publication number Publication date
HU211835A9 (en) 1995-12-28
DE3871596T3 (de) 2000-09-07
JP2726672B2 (ja) 1998-03-11
JPS63313728A (ja) 1988-12-21
ATE76750T1 (de) 1992-06-15
CA1314220C (en) 1993-03-09
AU607981B2 (en) 1991-03-21
DE3871596T2 (de) 1993-01-21
EP0286903B2 (en) 2000-03-29
DE3871596D1 (de) 1992-07-09
EP0286903A1 (en) 1988-10-19
GR3033721T3 (en) 2000-10-31
ES2042625T3 (es) 1993-12-16
ES2042625T5 (es) 2000-07-16
AU1387088A (en) 1988-10-06
EP0286903B1 (en) 1992-06-03

Similar Documents

Publication Publication Date Title
GR3004794T3 (cg-RX-API-DMAC7.html)
PT75777B (en) Process for the preparation of a composition for topical treatment of glaucoma and ocular hypertension
EP0308021A3 (en) Subsituted thieno (2,3-b)pyrole-5-sulfonamides as antiglaucoma agents
IE811654L (en) Ophthalmic composition
IE56177B1 (en) Celiprolol for the treatment of glaucoma
ES2053458T3 (es) Utilizacion de prostaglandinas a, b y c y derivados de las mismas, para el tratamiento de la hipertension ocular y glaucoma.
AU7266991A (en) 3-arylcarbonyl-1-aminoalkyl-1h-indole-containing antiglaucoma compositions
NZ227438A (en) Mastitis treatment using oxychlorosene derivatives; infusion applicator
EP0366279A3 (en) Ocular hypotensive agents
DE3872701D1 (de) Prostaglandin-derivate zur behandlung von glaucoma oder augenueberdruck.
TW427913B (en) Eye drop composition comprising pilocarpine and a β-blocking agent and process making the same
HU9302590D0 (en) Process and composition for treating eyes
AU687906B2 (en) Use of certain prostaglandin analogues to treat glaucoma and ocular hypertension
AU1545788A (en) A composition for the topical treatment of glaucoma or ocular hypertension
ATE117208T1 (de) Behandlung von intraokularem druck mit einer ophthalmischen synergistischen kombination.
AU591484B2 (en) Ophthalmic solutions and methods for improving the comfort and safety of contact lenses
DE69320329D1 (de) Topische Antiglaukoma Zusammensetzungen, enthaltend Karbonhydrasehemmer und Beta-Blocker
DE69116224D1 (de) Behandlung von intraokularem Druck mit einer synergischen Kombination
AU3581695A (en) Method and means for prevention and treatment of secondary cataract
EP0122178A3 (en) Benzothiazolesulfonamide derivatives for the topical treatment of elevated intraocular pressure
WO1998001099A3 (en) Method of treating retinal ischemia and glaucoma
HU9301364D0 (en) Homo-prostaglandines applicables for treatment of hypertension in eyes
EP0527748A4 (en) Use of prostaglandin f 3 alpha as an ocular hypotensive agent
JO1317B1 (en) Eye treatment
EP0309028A3 (en) Substituted thieno(2,3-b)furan-2-sulfonamides as antiglaucoma agents